ArticleJournal of clinical laboratory analysis2021

MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.